CJC-1295 with DAC is a modified GHRH(1-29) analog: the tetrasubstituted GRF(1-29) sequence conjugated to a Drug Affinity Complex (DAC), a maleimidopropionic acid–lysine linker. The CAS number listed below is for the base peptide, and the molecular weight is for the conjugate (peptide plus linker). We supply it as a 5mg vial of lyophilized powder for in vitro laboratory research.
Product Details
- Compound: CJC-1295 with DAC (Drug Affinity Complex)
- Base peptide CAS: 863288-34-0 (Modified GRF 1-29)
- Molecular Formula: C165H269N47O46
- Molecular Weight: 3647.2 Da
- Purity: 98.178% HPLC purity (Janoshik Analytical, batch PP2602-009A)
- Form: Lyophilized powder
- Size: 5mg
- Testing: View COA (Verified by Janoshik Analytical) →
Lab reports
The current batch report, from Janoshik Analytical, is linked in the Product Details above. Other published reports are listed in the lab report directory.
- Lab report directory
- Quality & testing: how we test
Common questions
What size is CJC-1295 with DAC sold in?
One 5mg vial per unit.
How is it supplied?
As lyophilized (freeze-dried) powder in a sealed vial.
How fast does it ship?
Orders ship from the US within 1–2 business days, and orders of $50 or more ship free.
Is it for human use?
No. CJC-1295 with DAC is sold for in vitro laboratory research only. It is not for human or veterinary use, and we give no guidance on use in people or animals.


